Skip to main content

Advanced Search

Advanced Search

Current Filters

Filter your query

Publication Types

Other

to

Grant

/

Estimating International Net Prices for Prescription Drugs

Grant Details

Grantee Organization
RAND Corporation

Principal Investigator
Andrew Mulcahy, Ph.D., M.P.P.

Term
7/1/21 - 6/30/22

Award Amount
$49,940

Approval Year

Related Program
Controlling Health Care Costs

Topics
Prescription Drugs

Grant Details

Grantee Organization
RAND Corporation

Principal Investigator
Andrew Mulcahy, Ph.D., M.P.P.

Term
7/1/21 - 6/30/22

Award Amount
$49,940

Approval Year

Related Program
Controlling Health Care Costs

Topics
Prescription Drugs

This project will compare manufacturer and net prices for prescription drugs outside the United States in order to summarize manufacturer-to-net ratios. Researchers will conduct a literature review for any new estimates of manufacturer-to-net price ratios outside the U.S. They will then collect product-level net sales of brand-name drugs by reviewing annual reports, SEC 10-K, and 20-F filings of the top 250 publicly traded pharmaceutical companies. Using IQVIA’s 2020 MIDAS data, the project will measure product-specific volumes in each country or region and calculate net prices in order to estimate the ratio of other-country manufacturer to net prices, the ratio of U.S. net prices to other-country manufacturer prices, and the ratio of U.S. net prices to other-country net prices.

Related Grants